BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26779834)

  • 1. Mechanisms mediating nitroglycerin-induced delayed-onset hyperalgesia in the rat.
    Ferrari LF; Levine JD; Green PG
    Neuroscience; 2016 Mar; 317():121-9. PubMed ID: 26779834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endothelial cells in antihyperalgesia induced by a triptan and β-blocker.
    Joseph EK; Levine JD
    Neuroscience; 2013 Mar; 232():83-9. PubMed ID: 23262231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal Model of Chronic Migraine-Associated Pain.
    Moye LS; Pradhan AAA
    Curr Protoc Neurosci; 2017 Jul; 80():9.60.1-9.60.9. PubMed ID: 28678396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms.
    Greco R; Demartini C; Zanaboni AM; Redavide E; Pampalone S; Toldi J; Fülöp F; Blandini F; Nappi G; Sandrini G; Vécsei L; Tassorelli C
    Cephalalgia; 2017 Nov; 37(13):1272-1284. PubMed ID: 27919017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial cells mediate mechanical stimulation-induced enhancement of endothelin hyperalgesia via activation of P2X2/3 receptors on nociceptors.
    Joseph EK; Green PG; Bogen O; Alvarez P; Levine JD
    J Neurosci; 2013 Feb; 33(7):2849-59. PubMed ID: 23407944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed inflammation in rat meninges: implications for migraine pathophysiology.
    Reuter U; Bolay H; Jansen-Olesen I; Chiarugi A; Sanchez del Rio M; Letourneau R; Theoharides TC; Waeber C; Moskowitz MA
    Brain; 2001 Dec; 124(Pt 12):2490-502. PubMed ID: 11701602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of glyceryl trinitrate provoked mast cell degranulation.
    Pedersen SH; Ramachandran R; Amrutkar DV; Petersen S; Olesen J; Jansen-Olesen I
    Cephalalgia; 2015 Dec; 35(14):1287-97. PubMed ID: 25724914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A naturalistic glyceryl trinitrate infusion migraine model in the rat.
    Ramachandran R; Bhatt DK; Ploug KB; Olesen J; Jansen-Olesen I; Hay-Schmidt A; Gupta S
    Cephalalgia; 2012 Jan; 32(1):73-84. PubMed ID: 22174360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of CGRP receptor antagonism in nitroglycerin-induced hyperalgesia.
    Greco R; Mangione AS; Siani F; Blandini F; Vairetti M; Nappi G; Sandrini G; Buzzi MG; Tassorelli C
    Cephalalgia; 2014 Jul; 34(8):594-604. PubMed ID: 24366981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral mechanisms underlying the essential role of P2X3,2/3 receptors in the development of inflammatory hyperalgesia.
    Oliveira MC; Pelegrini-da-Silva A; Tambeli CH; Parada CA
    Pain; 2009 Jan; 141(1-2):127-34. PubMed ID: 19081189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroacupuncture and A-317491 depress the transmission of pain on primary afferent mediated by the P2X3 receptor in rats with chronic neuropathic pain states.
    Wang WS; Tu WZ; Cheng RD; He R; Ruan LH; Zhang L; Gong YS; Fan XF; Hu J; Cheng B; Lai YP; Zou EM; Jiang SH
    J Neurosci Res; 2014 Dec; 92(12):1703-13. PubMed ID: 25041872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2X3 and P2X2/3 receptors mediate mechanical hyperalgesia induced by bradykinin, but not by pro-inflammatory cytokines, PGE₂ or dopamine.
    de Oliveira Fusaro MC; Pelegrini-da-Silva A; Araldi D; Parada CA; Tambeli CH
    Eur J Pharmacol; 2010 Dec; 649(1-3):177-82. PubMed ID: 20868656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic signaling mediates mechanical hyperalgesia through activation of P2X3 receptors in primary sensory neurons of rats with chronic pancreatitis.
    Wang S; Zhu HY; Jin Y; Zhou Y; Hu S; Liu T; Jiang X; Xu GY
    Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(8):G710-9. PubMed ID: 25634810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2X3 receptors contribute to muscle pain induced by static contraction by a mechanism dependent on neutrophil migration.
    de Melo Aquino B; da Silva Dos Santos DF; Jorge CO; Marques ACS; Teixeira JM; Parada CA; Oliveira-Fusaro MCG
    Purinergic Signal; 2019 Jun; 15(2):167-175. PubMed ID: 31115830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does nitric oxide mediate the vasodilator activity of nitroglycerin?
    Kleschyov AL; Oelze M; Daiber A; Huang Y; Mollnau H; Schulz E; Sydow K; Fichtlscherer B; Mülsch A; Münzel T
    Circ Res; 2003 Oct; 93(9):e104-12. PubMed ID: 14551241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a novel model of chronic migraine.
    Pradhan AA; Smith ML; McGuire B; Tarash I; Evans CJ; Charles A
    Pain; 2014 Feb; 155(2):269-274. PubMed ID: 24121068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of L-arginine in the vascular actions and development of tolerance to nitroglycerin.
    Abou-Mohamed G; Kaesemeyer WH; Caldwell RB; Caldwell RW
    Br J Pharmacol; 2000 May; 130(2):211-8. PubMed ID: 10807657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice.
    Bates EA; Nikai T; Brennan KC; Fu YH; Charles AC; Basbaum AI; Ptácek LJ; Ahn AH
    Cephalalgia; 2010 Feb; 30(2):170-8. PubMed ID: 19489890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the antihyperalgesic disruptor of endothelial cells, octoxynol-9, alter nociceptor function?
    Chen X; Green PG; Levine JD
    J Neurophysiol; 2014 Jul; 112(2):463-6. PubMed ID: 24790171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitroglycerin induces DNA damage and vascular cell death in the setting of nitrate tolerance.
    Mikhed Y; Fahrer J; Oelze M; Kröller-Schön S; Steven S; Welschof P; Zinßius E; Stamm P; Kashani F; Roohani S; Kress JM; Ullmann E; Tran LP; Schulz E; Epe B; Kaina B; Münzel T; Daiber A
    Basic Res Cardiol; 2016 Jul; 111(4):52. PubMed ID: 27357950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.